Results 251 to 260 of about 447,090 (290)
FHL2 deteriorates IL-1β induced inflammation, apoptosis, and extracellular matrix degradation in chondrocyte-like ATDC5 cells by mTOR and NF-ĸB pathways. [PDF]
Li Y, Wang F, Ji B, Amati A, Cao L.
europepmc +1 more source
Abstract Purpose Studies on deep learning dose prediction increasingly focus on 3D models with multiple input channels and data augmentation, which increases the training time and thus also the environmental burden and hampers the ease of re‐training. Here we compare 2D and 3D U‐Net models with clinical accepted plans to evaluate the appropriateness of
Rosalie Klarenberg+2 more
wiley +1 more source
Mx1-ing it up-Mitochondrial relay for interferon-dependent, unconventional IL-1β release in SLE monocytes. [PDF]
Dorfleutner A, Stehlik C, Jefferies CA.
europepmc +1 more source
Abstract Purpose This study aims to quantify and compare the dosimetric effects of varying thicknesses of StrataXRT, a silicone‐based gel, and other topical agents on the skin surface during volumetric modulated arc therapy (VMAT) for breast cancer.
Tenyoh Suzuki+13 more
wiley +1 more source
IL-1β promotes glutamate excitotoxicity: indications for the link between inflammatory and synaptic vesicle cycle in Ménière's disease. [PDF]
Zhang N+13 more
europepmc +1 more source
Abstract Background Dual‐energy cone‐beam CT (DE‐CBCT) has become subject of recent interest due to the ability to produce virtual monoenergetic images (VMIs) with improved soft‐tissue contrast and reduced nonuniformity artifacts. However, efficient production and optimization of VMIs remains an under‐explored part of DE‐CBCT's application.
Andrew Keeler+4 more
wiley +1 more source
CRNDE alleviates IL-1β-induced chondrocyte damage by modulating miR-31/NF-κB pathway. [PDF]
Liu J, Cheng J, Zhou H, Zuo Q, Liu F.
europepmc +1 more source
Abstract Purpose Volumetric‐modulated arc therapy (VMAT) treatment planning allows a compromise between a sufficient coverage of the planning target volume (PTV) and a simultaneous sparing of organs‐at‐risk (OARs). Particularly in the case of lung tumors, deciding whether it is possible or worth spending more time on further improvements of a treatment
Johann Brand+4 more
wiley +1 more source
Epigallocatechin-3-Gallate Ameliorates Diabetic Kidney Disease by Inhibiting the TXNIP/NLRP3/IL-1β Signaling Pathway. [PDF]
Wang Y+7 more
europepmc +1 more source
Design and validation of a novel dosimetry phantom for motion management audits
Abstract Background We present a novel phantom design for conducting end‐to‐end dosimetry audits for respiratory motion management of two anatomical treatment sites. The design enables radiochromic film measurements of the dose administered to the target throughout the respiratory cycle (motion‐included) and the dose delivered to the time‐averaged ...
Alex Burton+5 more
wiley +1 more source